Conversations in Healthcare
How Healx uses AI to transform rare disease drug discovery
Season 1, Ep. 42
In this episode of Conversations in Healthcare, Mike Ward speaks withDr.Tim Guilliams, the co-founder and CEO ofHealx.Healxis an artificial intelligence-powered technology company that's dedicated to helping rare disease patients access life improving treatments. Mike and Tim discuss the company’s innovative approach to drug discovery, choosing which rare diseases to targetand how patients are shaping their priorities. Learn more in the full episode, which was recorded in collaboration with One Nucleus's ON Helix conference(June 2021).
How the pandemic shifted Roche’s priorities and R&D investments
Season 1, Ep. 41
In this episode of Conversations in Healthcare, Mike Wardspeaks with Richard Erwin, general manager and managing director of Roche Products Limited (UK), which was recorded in collaboration with One Nucleus's ON Helix conference(June 2021). Richard shares how the pandemic has shifted Roche’s prioritiesand why the organization has heavily increased their investment in R&D. Learn more in the full episode.
Optimizing patient-first clinical trials with advanced site intelligence
Season 1, Ep. 40
In this episode of Conversations in Healthcare, Mike Wardspeaks with Oriol Serra,formerHead of Site IntelligenceandSelection at PfizerandSimon Andrews, Vice PresidentofRWDEngagementsand Innovations at Clarivate about optimizingpatient-firstclinical trial designand ensuringtrial groups align toreal-life populations and needs.The group discussesthe ins and outsto bringclinical trial management in-house, howtomodernizetrial designswith emerging data and intelligence, overcoming keychallenges and advice for other pharma andbiotechslooking to go down this path. Learn more in the full episode.
Showing the value of regulatory intelligence in pharma
Season 1, Ep. 39
In this episode of Conversations in Healthcare, Mike Wardspeaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca,and Céline Rodier, Senior Health Policy Manager at Clarivate,about strategies and tools to gather and assess regulatory intelligence, as well as KPIs and approaches to demonstrating ROI within your organization. Get actionable takeaways in the full episode.
Overcoming health inequity in the U.S. and the role of telehealth: Ideas and best practices from Cigna, Henry Ford Health System and the eHealth Initiative
Season 1, Ep. 38
Increased reliance on telehealth services has been one of the most significant care delivery shifts prompted by the COVID-19 pandemic. However, the pandemic has also thrown more light on the challenges of health inequity in the United States, especially among African American and Hispanic communities. We discuss these issues and potential solutions with leaders at theeHealth Initiative, Cigna and Henry Ford Health System.Panelists include:Wanneh Dixon, who is Director of Programs, Strategy & Development at eHealth InitiativeWill M. Lopez, the National Medical Director-Virtual Care and Senior Medical Director-Behavioral Health at Cigna; andDenise White-Perkins, who is not only the Vice Chair of Academic Affairs, Associate Residency Program Director, Department of Family Medicine, and Director, Healthcare Equity Initiatives, Office of System Diversity Equity and Inclusion at Henry Ford Health System but is also Clinical Associate Professor, at Wayne State University School of Medicine, Department of Family Medicine and Public Health Sciences
Best practices for university - healthcare partnerships: Learnings from the Institute of Cancer Research
Season 1, Ep. 37
In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Toby Richardson, who is Head of Business Development and Licensing; Deputy Director of Business and Innovation at The Institute of Cancer Research. Mike and Toby discuss how research collaborations between the ICR and biopharma companies help the Institute achieve its mission to make the discoveries that defeat cancer. Learn more in the full episode.
Best practices for university – healthcare partnerships: Learnings from Oxford
Season 1, Ep. 36
In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Phil Clare, the Deputy Director, Research Services (Knowledge Exchange and Engagement) at the University of Oxford. Mike and Dr. Clare discuss the key role that university research plays in shaping new medicines and technologies, and what that process looks like. Learn more in the full episode.
The evolution of the asset-centric approach in biotech venture capital
Season 1, Ep. 35
In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Francesco De Rubertis, a co-founder and managing partner at Medicxi, one of the most prominent financial supporters of innovative biotech activity. Francesco provides insights into how the biotech venture capital model has evolved in the past decades to an asset-centric approach, and discusses Centessa, which recently secured $250m in funding. Learn more in the full episode.